Skip to main content
. 2022 Nov 22;5(11):e2243232. doi: 10.1001/jamanetworkopen.2022.43232

Table 1. Demographic Data of the Clinical Groups in the DDI Study and Trønderbrain Cohorts.

Characteristic Patients, No. (%)
Control group AD group AD-MCI group AD-dementia group
DDI study cohort
No. 63 77 72 5
Age, median (range), y 62 (41-77) 68 (46-80)a 68 (46-80)a 73 (58-75)
Sex
Male 27 (42.9) 47 (61.0)a 44 (61.1)a 3 (60.0)
Female 36 (57.1) 30 (39.0)a 28 (38.9)a 2 (40.0)
APOE4 allele 25 (39.7) 56 (72.7)a 53 (73.6)a 3 (60.0)
MMSE score, median (range) 30 (27-30) 27 (18-30)a 27 (21-30)a 25 (18-28)a
Trønderbrain cohort
No. 54 49 30 19
Age, median (range), y 68 (57-84) 64 (54-72)a 64 (54-72)a 64 (54-69)a
Sex
Male 18 (33.3) 24 (49.0) 15 (50.0) 9 (47.4)
Female 36 (66.7) 25 (51.0) 15 (50.0) 10 (52.6)
APOE4 allele 20 (37.0) 42 (85.7) 24 (80.0)a 18 (94.7)a
MMSE score, median (range) 30 (28-30) 26 (16-30)a 28 (23-30)a 24 (16-27)a,b

Abbreviations: AD, Alzheimer disease; AD-MCI, AD with mild cognitive impairment; DDI, Dementia Disease Initiation; MMSE, Mini-Mental State Examination.

a

P < .01 compared with control group.

b

P < .01 compared with AD-MCI group.